Patents by Inventor Charles Mantel

Charles Mantel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6165459
    Abstract: Described are preferred processes and compositions for suppressing myeloid cells in mammals. Preferred processes and compositions involve the use of chemokines in synergistic combinations or while they are substantially completely in monomeric form (i.e. substantially free from their polymerized or aggregated forms).
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 26, 2000
    Assignee: Indiana University Foundation
    Inventors: Hal E. Broxmeyer, Scott Cooper, Charles Mantel, Li Lu
  • Patent number: 6143289
    Abstract: Described are preferred processes for suppressing proliferation of or for myeloprotecting myeloid cells in mammals. The processes involve the use of chemokines of the group Macrophage Inflammatory Protein-2.alpha. (MIP-2.alpha.), Platelet Factor 4 (PF4), Interleukin-8 (IL-8) and Macrophage Chemotactic and Activating Factor (MCAF), or involve the use of these chemokines or Macrophage Inflammatory Protein-1.alpha. (MIP-1.alpha.) in synergistic combinations or while they are substantially completely in monomeric form (i.e. substantially free from their polymerized or aggregated forms).
    Type: Grant
    Filed: December 9, 1992
    Date of Patent: November 7, 2000
    Assignee: Indiana University Foundation
    Inventors: Hal E. Broxmeyer, Scott Cooper, Charles Mantel, Li Lu